Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various… Read more
Market Cap & Net Worth: Prestige Consumer Healthcare Inc (PBV)
Prestige Consumer Healthcare Inc (F:PBV) has a market capitalization of $2.59 Billion (€2.52 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #4314 globally and #424 in its home market, demonstrating a -7.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prestige Consumer Healthcare Inc's stock price €52.50 by its total outstanding shares 48084010 (48.08 Million).
Prestige Consumer Healthcare Inc Market Cap History: 2015 to 2026
Prestige Consumer Healthcare Inc's market capitalization history from 2015 to 2026. Data shows growth from $2.25 Billion to $2.57 Billion (2.26% CAGR).
Prestige Consumer Healthcare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prestige Consumer Healthcare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.32x
Prestige Consumer Healthcare Inc's market cap is 2.32 times its annual revenue
1.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
12.30x
Prestige Consumer Healthcare Inc's market cap is 12.30 times its annual earnings
10.29x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.36 Billion | $806.25 Million | $99.91 Million | 2.93x | 23.63x |
| 2017 | $1.77 Billion | $882.06 Million | $69.39 Million | 2.01x | 25.56x |
| 2018 | $1.28 Billion | $1.04 Billion | $339.57 Million | 1.23x | 3.78x |
| 2019 | $1.78 Billion | $975.78 Million | -$35.80 Million | 1.82x | N/A |
| 2020 | $1.41 Billion | $963.01 Million | $142.28 Million | 1.47x | 9.92x |
| 2021 | $2.74 Billion | $943.37 Million | $164.68 Million | 2.90x | 16.63x |
| 2022 | $2.94 Billion | $1.09 Billion | $205.38 Million | 2.70x | 14.30x |
| 2023 | $2.74 Billion | $1.13 Billion | -$82.31 Million | 2.43x | N/A |
| 2024 | $3.68 Billion | $1.13 Billion | $209.34 Million | 3.27x | 17.57x |
| 2025 | $2.64 Billion | $1.14 Billion | $214.60 Million | 2.32x | 12.30x |
Competitor Companies of PBV by Market Capitalization
Companies near Prestige Consumer Healthcare Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Prestige Consumer Healthcare Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Prestige Consumer Healthcare Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Prestige Consumer Healthcare Inc's market cap moved from $2.25 Billion to $ 2.57 Billion, with a yearly change of 2.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.57 Billion | -2.80% |
| 2025 | €2.64 Billion | -28.19% |
| 2024 | €3.68 Billion | +34.23% |
| 2023 | €2.74 Billion | -6.72% |
| 2022 | €2.94 Billion | +7.21% |
| 2021 | €2.74 Billion | +94.06% |
| 2020 | €1.41 Billion | -20.56% |
| 2019 | €1.78 Billion | +38.51% |
| 2018 | €1.28 Billion | -27.67% |
| 2017 | €1.77 Billion | -24.87% |
| 2016 | €2.36 Billion | +4.90% |
| 2015 | €2.25 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Prestige Consumer Healthcare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.59 Billion USD |
| MoneyControl | $2.59 Billion USD |
| MarketWatch | $2.59 Billion USD |
| marketcap.company | $2.59 Billion USD |
| Reuters | $2.59 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.